buy

BioMarin Pharmaceutical Inc. buy Truist Financial Co.

BioMarin Pharmaceutical Inc.

Start price

€51.44

/ 50%

Target price

23.12.26

Performance (%)

Price

Summary

This prediction is currently active. With a performance of , the BUY prediction for BioMarin Pharmaceutical Inc. by Truist_Financial_Co_ is down slightly. This prediction currently runs until 23.12.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
BioMarin Pharmaceutical Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Truist_Financial_Co_ for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren

Prediction Buy

Perf. (%)

Target price 84.930

Change

Ends at

BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by analysts at Truist Financial Corporation from $80.00 to $100.00. They now have a "buy" rating on the stock.

Ratings data for BMRN provided by MarketBeat

Truist Financial Co.